Monday, April 3, 2017

Holden Daniels Post: When $65,000 a year for a drug is applauded

http://www.cnn.com/2017/04/03/health/prescription-drug-prices-public-opinion/index.html

two new drugs were cleared to hit the market last week: an eczema drug that will cost $37,000 per year and one for multiple sclerosis that will cost $65,000.
The drugs drew both praise and criticism for their five-digit price tags.
Researchers and patient organizations applauded the prices, which were cheaper than similar drugs on the market. They hoped the prices would please insurers and make the drugs more widely available.

i think that these may be way too overprice for drugs, but if they work thats great, and hopefully if people who are in need of these drugs, have good enough insurance to pay for most of it. 

No comments:

Post a Comment